FOR PATIENTS · SOURCE READING

Treatment of recurrent thymoma and thymic carcinoma

Source: Thymoma and Thymic Carcinoma, National Cancer Institute.

Source updated: January 11, 2023 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Treatment of recurrent thymoma and thymic carcinoma may include the following:

Source links and citations

Chemotherapy.

Source links and citations

Hormone therapy (octreotide) with or without prednisone.

Source links and citations

Targeted therapy.

Source links and citations

Surgery.

Source links and citations

Radiation therapy.

Source links and citations

A clinical trial of immune checkpoint inhibitor therapy with pembrolizumab.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice